These CD8+ cells predominantly target tumor cells by recognizing the major histocompatibility complex class I (MHC-I) molecules, referred to as human leukocyte antigen (HLA) in humans, present on the surface of tumor cells, thereby exerting their anti-tumor effects. The gene discussed is CD8A; the disease is neoplasm.